lanthanum carbonate

FDA Drug Profile — Fosrenol

lanthanum carbonate is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including Fosrenol. Available dosage forms: tablet, chewable, powder.

Drug details

Generic Name
lanthanum carbonate
Brand Names
Fosrenol
Application Number
NDA021468
Sponsor
Takeda Pharmaceuticals America, Inc.
NDC Codes
5
Dosage Forms
TABLET, CHEWABLE, POWDER
Routes
ORAL
Active Ingredients
LANTHANUM CARBONATE

Indications and Usage

1 INDICATIONS AND USAGE LANTHANUM CARBONATE is a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD). Management of elevated serum phosphorus levels in patients with ESRD usually includes all of the following: reduction in dietary intake of phosphate, removal of phosphate by dialysis, and reduction of intestinal phosphate absorption with phosphate binders. LANTHANUM CARBONATE is a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD). ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.